Form 8-K PEREGRINE PHARMACEUTICAL For: Mar 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Citi cuts investment banking analyst program to two years - Bloomberg
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
Peregrine Pharma (PPHM) Reports In-Line Q2 EPS
March 12, 2015 4:01 PM EDTPeregrine Pharma (NASDAQ: PPHM) reported Q2 EPS of ($0.08), in-line with the analyst estimate of ($0.08). Revenue for the quarter came in at $5.68 million versus the consensus estimate of $4.23 million.
For earnings history and earnings-related data on Peregrine Pharma (PPHM) click here.
... More


